IMMC Immunicon (MM)

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

Date of report (Date of earliest event reported): April 18, 2008

IMMUNICON CORPORATION

(Exact Name of Registrant Specified in Charter)

Registrant’s telephone number, including area code: (215) 830-0777

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the Registrant under any of the following provisions ( see General Instruction A.2. below):

On April 24, 2008, Immunicon Corporation (“Immunicon”) issued a press release announcing that on April 18, 2008, it received notification (the “Notice”) from The NASDAQ Stock Market (“NASDAQ”) indicating that trading in Immunicon’s common stock will be suspended and Immunicon’s common stock will be delisted from The NASDAQ Capital Market at the opening of business on April 29, 2008 (the “Delisting Date”), unless Immunicon appeals NASDAQ’s determination.

As previously disclosed in the Form 8-K filed by Immunicon on April 4, 2008, Immunicon had received notice from NASDAQ on April 2, 2008, indicating that Immunicon was not in compliance with Marketplace Rule 4310(c)(3) (the “Rule”) because Immunicon failed to have the minimum of $2,500,000 in stockholders’ equity required for continued listing on The NASDAQ Capital Market. Immunicon was provided until April 17, 2008 to submit a specific plan to achieve and sustain compliance with all applicable continued listing requirements of The NASDAQ Capital Market, including the Rule. On April 18, 2008, Immunicon notified NASDAQ that it would not submit such a plan but rather would pursue quotation of its common stock on the Over-the-Counter Bulletin Board (“OTCBB”).

As such, Immunicon does not intend to appeal NASDAQ’s determination of the Delisting Date and is in the process of transferring the quotation of its common stock to OTCBB. In that regard, Immunicon has been advised that a market maker has filed the necessary application with the Financial Industry Regulatory Authority to make a market in Immunicon’s common stock on OTCBB. It is Immunicon’s expectation that its common stock will be eligible for quotation on OTCBB on the Delisting Date.

A copy of Immunicon’s press release announcing receipt of the Notice is attached hereto as Exhibit 99.1 and is incorporated herein by reference.

(d) Exhibits.

99.1 – Press release

- 2 -

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: April 24, 2008

EXHIBIT INDEX

Immunicon (NASDAQ:IMMC)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Immunicon (NASDAQ:IMMC)
Historical Stock Chart
Von Jun 2023 bis Jun 2024